Ozempic-maker Novo open to upgrading US listing
Thanks: Financial Times | United Kingdom | 2026-09-23 04:00
According to a report by Financial Times… Boss Mike Doustdar says he sees ‘advantages’ in giving US investors direct access to Danish group’s stock complete report is on below link. Source: https://www.ft.com/content/00d53ca3-725f-4fa8-b452-cef562a13514?syn-25a6b1a6=1